<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" bill-type="olc" dms-id="H51FB367C27E14DEFB6799D5F266CF53C" key="H" public-private="public"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>115 HR 4897 IH: Women and Lung Cancer Research and Preventive Services Act of 2018</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2018-01-30</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">115th CONGRESS</congress><session display="yes">2d Session</session><legis-num display="yes">H. R. 4897</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20180130">January 30, 2018</action-date><action-desc><sponsor name-id="L000554">Mr. LoBiondo</sponsor> (for himself, <cosponsor name-id="N000127">Mr. Nolan</cosponsor>, <cosponsor name-id="B001278">Ms. Bonamici</cosponsor>, and <cosponsor name-id="C001105">Mrs. Comstock</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To require a study on women and lung cancer, and for other purposes.</official-title></form>
	<legis-body id="HD7A06353D406490DA134FBF541E30E81" style="OLC">
 <section id="HCE9BCBFDDD02491D9BA5BE214C8D6181" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Women and Lung Cancer Research and Preventive Services Act of 2018</short-title></quote>.</text> </section><section id="H5E0A8D575E2B4A078E8B5985F436C5A5"><enum>2.</enum><header>Findings</header><text display-inline="no-display-inline">Congress finds as follows:</text>
 <paragraph id="HB449F51306D14151905DC727E13B4636"><enum>(1)</enum><text>According to the American Cancer Society, in the United States, approximately 193 women die each day of lung cancer, or about one woman every 7 minutes.</text>
 </paragraph><paragraph id="H55FEB5347C9245439EAA3D8312FBE22F"><enum>(2)</enum><text>Lung cancer is the leading cause of cancer death among women.</text> </paragraph><paragraph id="H5E1763ED6D354A4A9B09C850C2DD5D02"><enum>(3)</enum><text>The American Cancer Society estimates that 70,500 women will die of lung cancer in 2018.</text>
 </paragraph><paragraph id="H8200FAEF6430403E85C1406998965D0A"><enum>(4)</enum><text>Studies have shown a higher incidence rate of lung cancer for women who were never smokers compared to men who were never smokers.</text>
 </paragraph><paragraph id="HC694775203504031BED9022B8DBDA664"><enum>(5)</enum><text>According to the 2014 report, <quote>The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General, 2014</quote>, the relative risk of developing lung cancer increased tenfold among female smokers between 1959 and 2010.</text>
 </paragraph><paragraph id="HD0990020A3484870972D4EFBE1139318"><enum>(6)</enum><text>According to the American Cancer Society, approximately 40 percent of lung cancers are adenocarcinoma, a subtype of non-small cell lung cancer, which is the most common type of cancer seen in non-smokers and is more common in women than in men.</text>
 </paragraph><paragraph id="HE4CE5A7E5E3343A1997234CB92C82397"><enum>(7)</enum><text>Exposure to radon accounts for approximately 21,000 deaths from lung cancer each year and is the leading cause of lung cancer in non-smokers.</text>
 </paragraph><paragraph id="HF7D288EBC8714DF586CC96CC6CFA111A"><enum>(8)</enum><text>A Government Accountability Office report published on October 22, 2015, called for the National Institutes of Health to do more in evaluating gender differences in research.</text>
 </paragraph><paragraph id="HAD171FFC717E407B828E8E2FC15101B6"><enum>(9)</enum><text>Additional research strategies and clinical trials are necessary to explore the differences in lung cancer risk factors, incidence, and treatment response in women, and to address the disparate impact of lung cancer on women who have never smoked.</text>
 </paragraph><paragraph id="H3337AB3E6CDA417CA4052B49F87187D9"><enum>(10)</enum><text>Lung cancer screening, which can detect lung cancer at its earliest, most curable stage, is a covered service available without cost-sharing for those at high risk.</text>
 </paragraph><paragraph id="H99ADDFBE3E3548E89A110BD29CEC3926"><enum>(11)</enum><text>Published peer-reviewed actuarial studies indicate that lung cancer screening individuals at high risk is cost-effective.</text>
 </paragraph><paragraph id="HE4F867EB8618448784A49B90F73F5A72"><enum>(12)</enum><text>The National Framework of Excellence in Lung Cancer Screening and Continuum of Care, launched in 2012, demonstrated that lung cancer screening can be safely and effectively carried out in community hospital settings around the Nation.</text>
 </paragraph><paragraph id="HB90902179642457FAA033EDABFBF27DF"><enum>(13)</enum><text>Information on the impact of lung cancer on women and the importance of early detection should be incorporated into all relevant public health awareness campaigns.</text>
 </paragraph></section><section id="H46FEFA3DDFA64C27818BB604FBB45316"><enum>3.</enum><header>Sense of Congress concerning women and lung cancer</header><text display-inline="no-display-inline">It is the sense of Congress that—</text> <paragraph id="H6A7A420DA90B4C8784CAE8EEF201F1B2"><enum>(1)</enum><text>there is a disparate impact of lung cancer on women and, in particular, on women who have never smoked;</text>
 </paragraph><paragraph id="HE2146806CF4641F982B747A18CF963CB"><enum>(2)</enum><text>additional research strategies to explore the differences in women with respect to lung cancer risk factors, incidence, histology, and response to treatment are justified and necessary;</text>
 </paragraph><paragraph id="H5FF2EEF2AB1C443E97618B2ED50A2F26"><enum>(3)</enum><text>the implementation of lung cancer preventive services for women should be accelerated; and</text> </paragraph><paragraph id="HB18B58C0B7CC45CB87294DED95E60DA6"><enum>(4)</enum><text>the public health agencies of the Federal Government should coordinate public education and awareness programs on the impact of lung cancer on women and the importance of early detection.</text>
			</paragraph></section><section id="H93D9E45050FF4562AB5D76209837953B"><enum>4.</enum><header>Study to evaluate and make recommendations for the acceleration of research on women and lung
			 cancer, greater access to preventive services, and strategic public
			 awareness and education campaigns</header>
 <subsection id="HF5707CEE5C33416F80EE5BC4A450D96D"><enum>(a)</enum><header>Study</header><text>The Secretary of Health and Human Services, in consultation with the Secretary of Defense and Secretary of Veterans Affairs, shall conduct an interagency study to evaluate the status of, and make recommendations for increased—</text>
 <paragraph id="HB7C9A35C39E7419EAB65400E072C2263"><enum>(1)</enum><text>research on women and lung cancer;</text> </paragraph><paragraph id="H20180FDD9E374F6E8E7689838DE104C6"><enum>(2)</enum><text>access to lung cancer preventive services; and</text>
 </paragraph><paragraph id="HC17DF674314649C6B16751D0795958C5"><enum>(3)</enum><text>strategic public awareness and education campaigns on lung cancer.</text> </paragraph></subsection><subsection id="HB26CA394D15247C1A7EED5C59705EC16"><enum>(b)</enum><header>Content</header><text>The study and recommendations under subsection (a) shall include—</text>
 <paragraph id="H3C42C31A72B84F018DD84C31B1CA106E"><enum>(1)</enum><text>a review and comprehensive report on the outcomes of previous research, the status of existing research activities, and knowledge gaps related to women and lung cancer in all agencies of the Federal Government;</text>
 </paragraph><paragraph id="HD0558A7CC99C44DF958C4F8255BDFA58"><enum>(2)</enum><text>specific recommendations for a collaborative, interagency, multidisciplinary, and innovative research program, that would—</text>
 <subparagraph id="H117073A71AEC49879CE5332B0A996030"><enum>(A)</enum><text>encourage innovative approaches to eliminate knowledge gaps in research;</text> </subparagraph><subparagraph id="H29B025485B0140BF810668BC6C6D0470"><enum>(B)</enum><text>evaluate environmental and genomic factors that may be related to the etiology of lung cancer in women; and</text>
 </subparagraph><subparagraph id="HB221DCE807CE49E78D6C94FAD97F9E82"><enum>(C)</enum><text>foster advances in imaging technology to improve risk assessment, diagnosis, treatment, and the simultaneous application of other preventive services;</text>
 </subparagraph></paragraph><paragraph id="H0DD24350FD5A40EAB75A9776DC2C6E9B"><enum>(3)</enum><text>recommendations for the development of a national lung cancer screening strategy with sufficient infrastructure and personnel resources to expand access to such screening, particularly among underserved populations; and</text>
 </paragraph><paragraph id="H592CFE8B4E884D199E201EF06E88A2BF"><enum>(4)</enum><text>recommendations for the development of a national public education and awareness campaign on women and lung cancer and the importance of early detection of lung cancer.</text>
 </paragraph></subsection><subsection id="H655497E57393448ABF2D6EE290E7B3BA"><enum>(c)</enum><header>Report</header><text>Not later than 180 days after the date of the enactment of this Act, the Secretary of Health and Human Services shall submit to Congress a report on the study conducted under subsection (a).</text>
			</subsection></section></legis-body></bill>


